Overview

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Status:
RECRUITING
Trial end date:
2026-06-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at how safe 89Zr-DFO-SC16.56 is, and how it is processed by the body in people with small cell lung cancer.
Phase:
PHASE1
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Treatments:
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic